{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:32:27Z","timestamp":1767652347970,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Portuguese Foundation for Science and Technology (FCT)","award":["UIDP\/00772\/2020","LA\/P\/0059\/2020"],"award-info":[{"award-number":["UIDP\/00772\/2020","LA\/P\/0059\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Melanocytic tumors are an important neoplastic disease in human and veterinary medicine, presenting large differences regarding tumor behavior between species. In horses, these tumors present a prolonged benign behavior, with rare invasiveness and metastases. In humans and small animals, invasion and metastasis have been associated with an Epithelial-Mesenchymal Transition, where the loss of E-cadherin expression plays a key role in tumor progression. This process and the role of E-cadherin have not yet been evaluated in equine melanocytic tumors. This study aimed to assess the immunolabeling of E-cadherin in equine melanocytic tumors and relate this with clinicopathological variables. A total of 72 equine melanocytic tumors were classified as benign and malignant and evaluated by immunohistochemistry for E-cadherin expression. A different pattern of immunostaining was found, contrasting with other species. A total of 69.4% of tumors presented raised immunolabeling of E-cadherin, with 70.7% of melanomas remaining with high expression. The typical loss of immunostaining was not seen in malignant melanomas and no differences were found between benign and malignant melanomas regarding E-cadherin immunostaining. The high immunolabeling of E-cadherin may contribute to the low invasiveness of these tumors, and it is in accordance with the benign behavior of equine melanoma and with the genetic factors associated with its development.<\/jats:p>","DOI":"10.3390\/ani13132216","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T02:28:46Z","timestamp":1688696926000},"page":"2216","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["E-Cadherin Immunostaining in Equine Melanocytic Tumors"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7328-2123","authenticated-orcid":false,"given":"Jos\u00e9","family":"Pimenta","sequence":"first","affiliation":[{"name":"Veterinary Sciences Department, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"CECAV\u2014Veterinary and Animal Research Center, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 5000-801 Vila Real, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-4560","authenticated-orcid":false,"given":"Isabel","family":"Pires","sequence":"additional","affiliation":[{"name":"Veterinary Sciences Department, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"CECAV\u2014Veterinary and Animal Research Center, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 5000-801 Vila Real, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3902-5374","authenticated-orcid":false,"given":"Justina","family":"Prada","sequence":"additional","affiliation":[{"name":"Veterinary Sciences Department, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"CECAV\u2014Veterinary and Animal Research Center, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 5000-801 Vila Real, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-6515","authenticated-orcid":false,"given":"M\u00e1rio","family":"Cotovio","sequence":"additional","affiliation":[{"name":"Veterinary Sciences Department, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"CECAV\u2014Veterinary and Animal Research Center, University of Tr\u00e1s-os-Montes e Alto Douro, 5000-801 Vila Real, Portugal"},{"name":"Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 5000-801 Vila Real, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Nishiya, A.T., Massoco, C.O., Felizzola, C.R., Perlmann, E., Batschinski, K., Tedardi, M.V., Garcia, J.S., Mendon\u00e7a, P.P., Teixeira, T.F., and Dagli, M.L.Z. (2016). Comparative Aspects of Canine Melanoma. Vet. Sci., 3.","DOI":"10.3390\/vetsci3010007"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41467-018-08081-1","article-title":"Cross-Species Genomic Landscape Comparison of Human Mucosal Melanoma with Canine Oral and Equine Melanoma","volume":"10","author":"Wong","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_3","unstructured":"Resende, L., Moreira, J., Prada, J., Queiroga, F.L., and Pires, I. (2015). Melanoma\u2014Current Clinical Management and Future Therapeutics, Intech."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.4632","article-title":"Cross-Species Models of Human Melanoma","volume":"238","author":"Patton","year":"2016","journal-title":"J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cveq.2013.08.008","article-title":"Equine Melanocytic Tumors","volume":"29","author":"Phillips","year":"2013","journal-title":"Vet. Clin. N. Am. Equine Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.2042-3292.2011.00368.x","article-title":"Melanoma in Horses: Current Perspectives","volume":"25","author":"Moore","year":"2013","journal-title":"Equine Vet. Educ."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/jvim.12133","article-title":"Coat Color Genotypes and Risk and Severity of Melanoma in Gray Quarter Horses","volume":"27","author":"Teixeira","year":"2013","journal-title":"J. Vet. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.185","article-title":"A Cis-Acting Regulatory Mutation Causes Premature Hair Graying and Susceptibility to Melanoma in the Horse","volume":"40","author":"Golovko","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/eve.12012","article-title":"Malignant Melanoma of the Third Eyelid in a Horse","volume":"27","author":"Albanese","year":"2015","journal-title":"Equine Vet. Educ."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/eve.12815","article-title":"Primary Corneal Malignant Melanoma in a Horse","volume":"31","author":"Strauss","year":"2019","journal-title":"Equine Vet. Educ."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2046-0481-66-22","article-title":"Malignant Melanoma in a Grey Horse: Case Presentation and Review of Equine Melanoma Treatment Options","volume":"66","author":"Papakonstantinou","year":"2013","journal-title":"Ir. Vet. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/eve.12105","article-title":"Anaplastic Malignant Melanoma of the Tail in Non-Grey Horses","volume":"26","author":"Valentine","year":"2014","journal-title":"Equine Vet. Educ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.21836\/PEM20140410","article-title":"Aetiology, Clinical Presentation and Current Treatment Options of Equine Malignant Melanoma\u2014A Review of the Literature","volume":"30","author":"Cavalleri","year":"2014","journal-title":"Pferdeheilkunde"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)65023-7","article-title":"E-Cadherin Expression in Melanoma Cells Restores Keratinocyte-Mediated Growth Control and down-Regulates Expression of Invasion-Related Adhesion Receptors","volume":"156","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"D\u2019arcy, C., and Kiel, C. (2021). Cell Adhesion Molecules in Normal Skin and Melanoma. Biomolecules, 11.","DOI":"10.3390\/biom11081213"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"626129","DOI":"10.3389\/fonc.2020.626129","article-title":"Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities","volume":"10","author":"Eddy","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10555-021-09960-8","article-title":"Rethinking the Biology of Metastatic Melanoma: A Holistic Approach","volume":"40","author":"Vandyck","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1541-7786.MCR-20-0595","article-title":"Cell Adhesion Molecules in Plasticity and Metastasis","volume":"19","author":"Smart","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0749.2005.00235.x","article-title":"Adhesion, Migration and Communication in Melanocytes and Melanoma","volume":"18","author":"Haass","year":"2005","journal-title":"Pigment. Cell Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0300985812457792","article-title":"Alteration in E-Cadherin\/\u03b2-Catenin Expression in Canine Melanotic Tumors","volume":"50","author":"Han","year":"2013","journal-title":"Vet. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00008390-199604000-00007","article-title":"E Cadherin Expression in Human Melanoma","volume":"6","author":"Dane","year":"1996","journal-title":"Melanoma Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0300985820934385","article-title":"E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis","volume":"57","author":"Silvestri","year":"2020","journal-title":"Vet. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40364-021-00299-4","article-title":"E-Cadherin Expression in Human Tumors: A Tissue Microarray Study on 10,851 Tumors","volume":"9","author":"Burandt","year":"2021","journal-title":"Biomark. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.rvsc.2017.09.009","article-title":"Gene Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and Their Tissue Inhibitors in Canine Oral Tumors","volume":"113","author":"Pisamai","year":"2017","journal-title":"Res. Vet. Sci."},{"key":"ref_25","unstructured":"Pires, I., Gomes, J., Prada, J., Pereira, D., and Queiroga, F.L. (2013). Recent Advances in the Biology, Therapy and Management of Melanoma, InTech."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Campagne, C., Jul\u00e9, S., Bernex, F., Estrada, M., Aubin-Houzelstein, G., Panthier, J.-J., and Egidy, G. (2012). RACK1, a Clue to the Diagnosis of Cutaneous Melanomas in Horses. BMC Vet. Res., 8.","DOI":"10.1186\/1746-6148-8-95"},{"key":"ref_27","first-page":"2713","article-title":"Decrease of E-Cadherin Expression in Canine Cutaneous Histiocytoma Appears to Be Related to Its Spontaneous Regression","volume":"29","author":"Pires","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2013.05.009","article-title":"Directed Phenotype Switching as an Effective Antimelanoma Strategy","volume":"24","author":"Montenegro","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2017.01.029","article-title":"Potential Therapeutic Targets of Epithelial\u2013Mesenchymal Transition in Melanoma","volume":"391","author":"Pearlman","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/1055-9965.EPI-07-2729","article-title":"Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma","volume":"17","author":"Kreizenbeck","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.rvsc.2020.04.007","article-title":"ZEB and Snail Expression Indicates Epithelial-Mesenchymal Transition in Canine Melanoma","volume":"131","author":"Veloso","year":"2020","journal-title":"Res. Vet. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Armando, F., Mazzola, F., Ferrari, L., and Corradi, A. (2023). An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?. Vet. Sci., 10.","DOI":"10.3390\/vetsci10010019"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/vco.12464","article-title":"Canine Oral Primary Melanoma Cells Exhibit Shift to Mesenchymal Phenotype and Phagocytic Behaviour","volume":"17","author":"Schmid","year":"2019","journal-title":"Vet. Comp. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Loh, C.Y., Chai, J.Y., Tang, T.F., Wong, W.F., Sethi, G., Shanmugam, M.K., Chong, P.P., and Looi, C.Y. (2019). The E-Cadherin and n-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges. Cells, 8.","DOI":"10.3390\/cells8101118"},{"key":"ref_35","unstructured":"Knottenbelt, D.C., Patterson-Kane, J.C., and Snalune, K.L. (2015). Clinical Equine Oncology, Elsevier."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2746\/042516403776114234","article-title":"Equine Melanoma in a Population of 296 Grey Lipizzaner Horses","volume":"35","author":"Seltenhammer","year":"2003","journal-title":"Equine Vet. J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sundstr\u00f6m, E., Imsland, F., Mikko, S., Wade, C., Sigurdsson, S., Rosengren Pielberg, G., Golovko, A., Curik, I., Seltenhammer, M.H., and S\u00f6lkner, J. (2012). Copy Number Expansion of the STX17 Duplication in Melanoma Tissue from Grey Horses. BMC Genom., 13.","DOI":"10.1186\/1471-2164-13-365"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Curik, I., Druml, T., Seltenhammer, M., Sundstr\u00f6m, E., Pielberg, G.R., Andersson, L., and S\u00f6lkner, J. (2013). Complex Inheritance of Melanoma and Pigmentation of Coat and Skin in Grey Horses. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003248"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.jid.2021.02.740","article-title":"TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, Which Prevents Activation of E-Cadherin by MITF","volume":"141","author":"Peres","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00018-014-1791-0","article-title":"MITF in Melanoma: Mechanisms behind Its Expression and Activity","volume":"72","author":"Hartman","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e63093","DOI":"10.7554\/eLife.63093","article-title":"Mitf Reprograms the Extracellular Matrix and Focal Adhesion in Melanoma","volume":"10","author":"Dilshat","year":"2021","journal-title":"eLife"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/exd.12724","article-title":"Microphthalmia-Associated Transcription Factor Expression Levels in Melanoma Cells Contribute to Cell Invasion and Proliferation","volume":"24","author":"Vachtenheim","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jid.2019.11.025","article-title":"Cellular Phenotypic Plasticity of Cutaneous Melanoma: A Complex Puzzle","volume":"140","author":"Joshi","year":"2020","journal-title":"J. Investig. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S1470-2045(07)70140-7","article-title":"Active versus Passive Mechanisms in Metastasis: Do Cancer Cells Crawl into Vessels, or Are They Pushed?","volume":"8","author":"Bockhorn","year":"2007","journal-title":"Lancet Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/CMR.0000000000000138","article-title":"MelanA-Negative Spindle-Cell Associated Melanoma, a Distinct Inflammatory Phenotype Correlated with Dense Infiltration of CD163 Macrophages and Loss of E-Cadherin","volume":"25","author":"Steiniche","year":"2015","journal-title":"Melanoma Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1600-0749.2004.00192.x","article-title":"Comparative Histopathology of Grey-Horse-Melanoma and Human Malignant Melanoma","volume":"17","author":"Seltenhammer","year":"2004","journal-title":"Pigment. Cell Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0300985810390717","article-title":"Prognostic Markers for Canine Melanocytic Neoplasms: A Comparative Review of the Literature and Goals for Future Investigation","volume":"48","author":"Smedley","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/eve.13159","article-title":"Melanocytic Tumours in Horses","volume":"32","author":"Sullins","year":"2020","journal-title":"Equine Vet. Educ."},{"key":"ref_49","first-page":"296","article-title":"Skin Diseases Refresher Melanoma","volume":"18","author":"Pilsworth","year":"2006","journal-title":"Equine Vet. Educ."},{"key":"ref_50","unstructured":"Knottenbelt, D.C., Patterson-Kane, J.C., and Snalune, K.L. (2015). Clinical Equine Oncology, Elsevier."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Bellenghi, M., Puglisi, R., Pontecorvi, G., De Feo, A., Car\u00e8, A., and Mattia, G. (2020). Sex and Gender Disparities in Melanoma. Cancers, 12.","DOI":"10.3390\/cancers12071819"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0974-6102.92207","article-title":"Melanomas and Their Effect on the Grey Horse","volume":"4","author":"Burden","year":"2011","journal-title":"Young Sci. J."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/13\/13\/2216\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:07:02Z","timestamp":1760126822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/13\/13\/2216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":52,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ani13132216"],"URL":"https:\/\/doi.org\/10.3390\/ani13132216","relation":{},"ISSN":["2076-2615"],"issn-type":[{"type":"electronic","value":"2076-2615"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}